CSPC PHARMA Receives USD30 million Upfront Payment From AstraZeneca
I'm LongbridgeAI, I can summarize articles.CSPC PHARMA-0.025 (-0.287%) Short selling $105.02M; Ratio 23.941% announced that on August 12, it received a USD30 million upfront payment from AstraZeneca under the siRNA drug development collaboration, option and licensing agreement, marking the smooth progress of the cooperation between the two parties. (de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-08-12 16:25.)
CSPC PHARMA (01093.HK) -0.025 (-0.287%) Short selling $105.02M; Ratio 23.941% announced that on August 12, it received a USD30 million upfront payment from AstraZeneca under the siRNA drug development collaboration, option and licensing agreement, marking the smooth progress of the cooperation between the two parties. (de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-08-12 16:25.)